These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10348465)
1. Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease. Barbiroli B; Martinelli P; Patuelli A; Lodi R; Iotti S; Cortelli P; Montagna P Mov Disord; 1999 May; 14(3):430-5. PubMed ID: 10348465 [TBL] [Abstract][Full Text] [Related]
2. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG. Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175 [TBL] [Abstract][Full Text] [Related]
3. 99mTc-TRODAT-1 imaging of multiple system atrophy. Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673 [TBL] [Abstract][Full Text] [Related]
4. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Jellinger KA; Seppi K; Wenning GK Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088 [TBL] [Abstract][Full Text] [Related]
5. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism. Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209 [TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107 [TBL] [Abstract][Full Text] [Related]
7. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy. Visanji NP; Collingwood JF; Finnegan ME; Tandon A; House E; Hazrati LN J Parkinsons Dis; 2013; 3(4):523-37. PubMed ID: 24113558 [TBL] [Abstract][Full Text] [Related]
8. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson's disease. Kim M; Jung JH; Park J; Son H; Jeong SJ; Oh SJ; Cho SY; Parkinsonism Relat Disord; 2015 Mar; 21(3):205-10. PubMed ID: 25534084 [TBL] [Abstract][Full Text] [Related]
9. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation. Shao N; Yang J; Shang H Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255 [TBL] [Abstract][Full Text] [Related]
10. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Yoshita M; Hayashi M; Hirai S Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173 [TBL] [Abstract][Full Text] [Related]
11. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes. Lee JH; Kim TH; Mun CW; Kim TH; Han YH J Neurol; 2015 Aug; 262(8):1876-82. PubMed ID: 26016683 [TBL] [Abstract][Full Text] [Related]
13. Aspects of human bioenergetics as studied in vivo by magnetic resonance spectroscopy. Barbiroli B; Iotti S; Lodi R Biochimie; 1998 Oct; 80(10):847-53. PubMed ID: 9893943 [TBL] [Abstract][Full Text] [Related]
14. Apraxia in Parkinson's disease and multiple system atrophy. Uluduz D; Ertürk O; Kenangil G; Ozekmekçi S; Ertan S; Apaydin H; Erginöz E Eur J Neurol; 2010 Mar; 17(3):413-8. PubMed ID: 20050896 [TBL] [Abstract][Full Text] [Related]
15. Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225 [TBL] [Abstract][Full Text] [Related]
16. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056 [TBL] [Abstract][Full Text] [Related]
17. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733 [TBL] [Abstract][Full Text] [Related]
18. Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease. Van Laere K; Clerinx K; D'Hondt E; de Groot T; Vandenberghe W J Nucl Med; 2010 Apr; 51(4):588-95. PubMed ID: 20237023 [TBL] [Abstract][Full Text] [Related]
19. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease. Kaut O; Kuchelmeister K; Moehl C; Wüllner U J Chem Neuroanat; 2019 Mar; 96():41-48. PubMed ID: 30557654 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease. Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]